The high-flow oxygen therapy system, also called the THRIVE (Transnasal Humidified Rapid-Insufflation Ventilatory Exchange) system, appears to provide better patient safety than conventional techniques. Panendoscopy is a very common diagnostic procedure in ENT surgery. The general anesthesia during the diagnostic panendoscopy is a good representation of the induction stage. Indeed, the procedure of preoxygenation preceding anesthetic induction and direct laryngoscopy corresponds to the airway management that is an integral part of each general anesthesia. This is why researchers are studying it in particular to improve patient safety during difficult intubations. The paradox is that there is no consensus on the anesthetic strategy for this procedure that counts four main methods for the airway management of patients requiring an ENT panendoscopy. In our center, the investigators use, in most situations, a variant of spontaneous ventilation described by Y. Jacquet et al., with the difference that the investigators use a transglottic oxygenation probe during the procedure. During laryngoscopy, the operator positions a naso-tracheal tube after local anesthesia of the vocal cords. The oxygen flow is reduced to 3 L/min before the exploration procedure. The arrival in operating theaters of the Optiflow™ system, developed by the New Zealand Company Fisher \& Paykel Healthcare, has led to a rethinking of the way oxygen is delivered. This device allows the administration of a flow rate of up to 70 L/min while delivering heated gases.
This device allows the administration of a flow rate of up to 70 L/min while delivering heated gases. The benefit of Optiflow™ no longer needs to be demonstrated for certain intensive care patients. In the field of Anesthesia, the number of publications raised up since the increase in the non-hypoxemic apnea time during general anesthesia is never equaled by other methods. What is known is that panendoscopy under general anesthesia in spontaneous ventilation is not unanimously accepted due to a higher risk regarding the time allowed for apnea, and laryngospasm complications. High-flow oxygen delivery provide a longer safe apnea time for patient safety. The aim of this investigation is to prove that high-flow oxygen therapy improves patient safety during general anesthesia for ENT panendoscopy. This should allow answering the question: shouldn't very high flow oxygenation be systematically offered for this procedure? Currently, there is no consensus as to the anaesthetic strategy for this procedure, if our hypothesis is verified; the Optiflow™ system could become de gold standard of the management of the upper airway during the ENT procedure.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
160
Oxygen therapy during general anesthesia for ENT panendoscopy
Centre Antoine Lacassagne
Nice, France
Incidence of arterial desaturation
The O2 saturation defined as SpO2 \<95% will be collected each time it reaches 94% or less
Time frame: 1 day, during the procédure
Measure the non-hypoxemic apnea time
Non-hypoxemic apnea time will be measured as soon as the SpO2 parameter is between 100 and 95%
Time frame: 1 day, during the procédure
Incidence of the use of manual ventilation
Interruption of the surgical procedure for use of manual ventilation with a facemask will be recorded.
Time frame: 1 day, during the procedure
Incidence of the use of tracheal intubation
Conversion from the OHD oxygenation technique to the standard technique will be recorded
Time frame: 1 day, during the procedure
Incidence of the use of neuromuscular blocking drugs
The use of neuromuscular blocking drugs will be recorded
Time frame: 1 day, during the procedure
Incidence of emergency tracheostomy
The performance of an emergency tracheostomy will be recorded
Time frame: 1 day, during the procedure
Incidence of complications in SSPI and the complication rate on D1 after the panendoscopy procedure
Occurrence of complications in SSPI and on D1 after the panendoscopy procedure will be recorded. Complication in SSPI is define as prolonged desaturation requiring a supply of ventilation whatever the modalities, symptomatic hypercapnia or cardiovascular complications.
Time frame: Through study completion, up to 2 days
Correlation between sedation dose and duration of non-hypoxemic apnea
Correlation between the dose of sedation and the duration of non-hypoxemic apnea will be evaluated using Spearman's R coefficient
Time frame: 1 day, during the procedure
Evaluation of the technique fluctuation
Hypoxic desaturation will be reported by acts and by technique
Time frame: 1 day, during the procedure
Operator satisfaction
Operator's satisfaction will be noted at the end of each procedure using a visual analogic scale from 1 to 6
Time frame: 1 day, after the procedure
Patient satisfaction
Patient satisfaction will be recorded using a scale from 1 to 6
Time frame: up to 2 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.